Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis
X. Garcia-del-Muro, Catalina Vadell, G. Pérez Manga et al. · European Journal of Cancer · 1998
Cited by 20 works. doi:10.1016/s0959-8049(97)00367-5
Authors
- Catalina Vadell
- G. Pérez Manga
- Isabel Bover
- Juli Rifà
- Miguel Beltrán
- Ma.M. Barros
- J.R. Germà
- Xavier Fabregat
- Vı́ctor Moreno
- Pau Viladiu
References
- Comparison of the 5-Hydroxytryptamine 3 (Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
- Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
- Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.
- A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.
- Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis
- Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.
- Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
- Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
- Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients
- Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis